$2.07 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 81 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PTLA | New | PORTOLA PHARMACEUTIC | $32,498,000 | – | 1,593,039 | +100.0% | 1.57% | – |
ACAD | New | ACADIA PHARMACEUTCLS | $19,312,000 | – | 690,700 | +100.0% | 0.93% | – |
PRTA | New | PROTHENA CORP PLC | $16,386,000 | – | 398,100 | +100.0% | 0.79% | – |
SAGE | New | SAGE THERAPEUTICS | $13,500,000 | – | 421,084 | +100.0% | 0.65% | – |
TMH | New | TEAM HEALTH HLDGS | $11,247,000 | – | 269,000 | +100.0% | 0.54% | – |
AVXS | New | AVEXIS INC | $8,107,000 | – | 297,600 | +100.0% | 0.39% | – |
NUVA | New | NUVASIVE INC | $8,090,000 | – | 166,300 | +100.0% | 0.39% | – |
AMSG | New | AMSURG CORP | $7,191,000 | – | 96,400 | +100.0% | 0.35% | – |
COLL | New | COLLEGIUM PHARMACEUT | $5,343,000 | – | 294,400 | +100.0% | 0.26% | – |
MOH | New | MOLINA HEALTHCARE | $5,224,000 | – | 81,000 | +100.0% | 0.25% | – |
ABMD | New | ABIOMED INC | $5,082,000 | – | 53,600 | +100.0% | 0.25% | – |
ARAY | New | ACCURAY INC | $4,462,000 | – | 771,950 | +100.0% | 0.22% | – |
PRAH | New | PRA HEALTH SCIENCE | $4,182,000 | – | 97,800 | +100.0% | 0.20% | – |
IART | New | INTEGRA LIFESCIENCE | $4,079,000 | – | 60,560 | +100.0% | 0.20% | – |
SCAI | New | SURGICAL CARE AFFI | $3,675,000 | – | 79,400 | +100.0% | 0.18% | – |
WMGI | New | WRIGHT MED GROUP N V | $3,020,000 | – | 181,935 | +100.0% | 0.15% | – |
ENTL | New | ENTELLUS MED INC | $2,722,000 | – | 149,665 | +100.0% | 0.13% | – |
ANAC | New | ANACOR PHARMACEUTI | $2,485,000 | – | 46,500 | +100.0% | 0.12% | – |
LCI | New | LANNETT CO INC | $2,330,000 | – | 129,957 | +100.0% | 0.11% | – |
TNDM | New | TANDEM DIABETES CA | $2,340,000 | – | 268,690 | +100.0% | 0.11% | – |
XENT | New | INTERSECT ENT INC | $2,195,000 | – | 115,540 | +100.0% | 0.11% | – |
NVAX | New | NOVAVAX INC | $2,129,000 | – | 412,500 | +100.0% | 0.10% | – |
New | PRONAI THERAPEUTICS | $1,359,000 | – | 201,660 | +100.0% | 0.07% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
PFIZER INC | 35 | Q3 2023 | 6.3% |
MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
SEQUENOM INC | February 12, 2014 | ? | ? |
INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-12 |
SC 13G/A | 2023-02-13 |
SC 13G | 2023-02-13 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.